June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
A Sticky Situation
Author Affiliations & Notes
  • Christine E Greer
    Ophthalmology, University of Southern California, Pasadena, California, United States
  • Jesse Berry
    Ophthalmology, University of Southern California, Pasadena, California, United States
  • Footnotes
    Commercial Relationships   Christine Greer, None; Jesse Berry, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1789. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Christine E Greer, Jesse Berry; A Sticky Situation. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1789.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ocular surface squamous neoplasia (OSSN) is the most common non pigmented ocular neoplasm, encompassing a spectrum of conjunctival and corneal epithelial neoplastic tumors, from conjunctival intraepithelial neoplasia (CIN) to squamous cell carcinoma. In recent years, treatment has shifted away from traditional therapies such as surgical excision and cryotherapy in favor of medical management with topical chemotherapeutic agents. Primary medical therapy with topical chemotherapeutic agents have demonstrated resolutions rates between 80-100% (Karp 2010) and recurrence rates consistently less than 20% (Karp 2010). We report a case of a 73 year old Hispanic female with OSSN with invasion to the eyelid margin (grade T3) in which the ocular surface was treated with good response to topical 5-FU with residual lid margin disease that responded to interferon injections. To the author's knowledge, this is the first published report of lid involving OSSN lid treated with IFN injections.

Methods : Given extent of disease, chemoreduction with topical 5-FU was initiated. The patient underwent treatment for two weeks, followed by a two week holiday. The patient was treated with a total of six weeks of 5-FU. Ultimately, the ocular surface disease resolved, however, a three mm diameter canalicular involving lower lid lesion remained. The decision was made to treat with interferon alpha-2-b (IFN) injections.

Results : The patient underwent four series of weekly IFN injections (intinally 3000 U/0.5ml and 8000U/0.5 ml thereafter) before clinical resolution confirmed by anterior segment optical coherence tomography.

Conclusions : To our knowledge this is the first reported case of OSSN of the lid treated with IFN injections.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

External slit lamp photograph of the right eye depicting extensive ocular surface neoplasia, with extension to the lower lid.

External slit lamp photograph of the right eye depicting extensive ocular surface neoplasia, with extension to the lower lid.

 

External slit lamp photograph of the right eye demonstrating a residual lower lid lesion, despite fully treated ocular surface disease

External slit lamp photograph of the right eye demonstrating a residual lower lid lesion, despite fully treated ocular surface disease

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×